BioGeneration Ventures Fund III secures EUR66m
BioGeneration Ventures (BGV), a early stage life sciences venture capital firm, has secured investments from the European Investment Fund (EIF) and other new investors in BGV III, taking the fund’s total capital commitments to EUR66 million. The Fund is supported by the “InnovFin – EU Finance for Innovators” initiative under